Table of Contents
Advances in Geriatrics
Volume 2014, Article ID 302712, 14 pages
http://dx.doi.org/10.1155/2014/302712
Review Article

CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design

Department of Neurology, Knight Alzheimer’s Disease Research Center, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA

Received 13 April 2014; Revised 30 June 2014; Accepted 1 July 2014; Published 14 August 2014

Academic Editor: Stephen D. Ginsberg

Copyright © 2014 Anne M. Fagan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anne M. Fagan, “CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design,” Advances in Geriatrics, vol. 2014, Article ID 302712, 14 pages, 2014. https://doi.org/10.1155/2014/302712.